Randomised, parallel-group, multicentre, multinational phase 2 study comparing edoxaban, an oral factor Xa inhibitor, with warfarin for stroke prevention in patients with atrial fibrillation.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples